1 / 21

10 year Roadmap 95-95 by 2025 David W. Denning President GAFFI The University of Manchester

10 year Roadmap 95-95 by 2025 David W. Denning President GAFFI The University of Manchester. GAFFI is calling for: By 2025, ensure that 95% of people with serious fungal disease are diagnosed and 95% treated. www.GAFFI.org. Deaths from fungal infection need to fall. www.GAFFI.org.

hendricks
Download Presentation

10 year Roadmap 95-95 by 2025 David W. Denning President GAFFI The University of Manchester

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 10 year Roadmap 95-95 by 2025David W. DenningPresident GAFFIThe University of Manchester

  2. GAFFIis calling for: By 2025, ensure that 95% of people with serious fungal disease are diagnosed and 95% treated www.GAFFI.org

  3. Deaths from fungal infection need to fall www.GAFFI.org

  4. 1.5 million deaths from AIDS in 2013330,000 due to TB700,000 due to fungal disease? www.GAFFI.org

  5. Diagnosis Ensure that affordable diagnostic tests for all common and uncommon fungal infections are made available and focused on rapid, non-culture testing. www.GAFFI.org

  6. GAFFI is calling for: At least one expert in fungal disease diagnostics in each country. The focus should be on non-culture-based tests. Strong clinical links are very important. www.GAFFI.org

  7. Core tests for mycology reference laboratories www.GAFFI.org

  8. Treatment – GAFFI’s aim Ensure distribution of antifungal agents on the WHO Essential Medicine List to reach all those who need them. www.GAFFI.org

  9. WHO Essential Medicines List Griseofulvin Fluconazole Amphotericin B Flucytosine Topicals GAFFI has applied for itraconazole to be added www.GAFFI.org

  10. www.gaffi.org/why/burden-of-disease-maps/

  11. www.gaffi.org/why/burden-of-disease-maps/

  12. GAFFI is calling for: a network of expert clinicians and ‘train the trainer’ programs, supported by clinical guidelines, in each country and region www.GAFFI.org

  13. www.LIFE-Worldwide.org

  14. ISHAM members and mycology experts need to grasp these issues and try and impact on clinical practice across the world and in each part of each country www.GAFFI.org

  15. Public health Public health mycology is a non-existent discipline, which needs fostering by Schools of Public Health, scholarship programs, development of surveillance networks and incorporation into mainstream global health institutions. www.GAFFI.org

  16. Global public health and fungal diseases • WHO Cryptococcal/HIV guidelines (2013/5) • Amphotericin B and flucytosine placed on WHO Essential Medicine List (2013) • Mycetoma accepted as Neglected Tropical Disease (2013) • WHO skin and oral health in HIV guidelines (2014) www.GAFFI.org

  17. Global public health and fungal diseases • WHO Cryptococcal/HIV guidelines (2013/5) • Amphotericin B and flucytosine placed on WHO Essential Medicine List (2013) • Mycetoma accepted as Neglected Tropical Disease (2013) • WHO skin and oral health in HIV guidelines (2014) • Very few national surveillance programs • DALYs and QALYs only for cryptococcal meningitis • GBD/IHME efforts have ignored all fungal diseases • Economic modelling only for invasive mycoses in high income countries www.GAFFI.org

  18. A major goal is to reduce AIDS deaths due to fungal infections Support 90-90-90 Reduce AIDS deaths to <500,000 by 2020 Focus on the commonest lethal fungal infections - cryptococcal meningitis, Pneumocystis pneumonia, disseminated histoplasmosis and chronic pulmonary aspergillosis after tuberculosis www.GAFFI.org

  19. Reducing AIDS deaths due to fungal infections: www.GAFFI.org

  20. Friends of GAFFI - our 4 tasks • Universal access to diagnostics for serious fungal disease • Universal access to antifungal agents • Accurate data on the number and severity of fungal infections • Health professional education related to better recognition and care for patients with serious fungal disease www.GAFFI.org

  21. ‘Leave no one behind’ Too many people have no access to life-saving diagnostics and antifungal medicine This has to change www.GAFFI.org

More Related